[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Eric Vivier<\/i><\/u><\/presenter>. Centre d'Immunologie INSERM, Marseille, France","CSlideId":"","ControlKey":"0763e2f7-30b0-4a27-a44c-1ae150cda2f9","ControlNumber":"342","DisclosureBlock":"&nbsp;<b>&nbsp;E. Vivier:<\/b>  ; Innate Pharma. ; Innate Pharma.","End":"4\/9\/2022 10:01:00 AM","HasWebcast":null,"Highlights":[],"Id":"197","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Eric Vivier, PhD","PresenterKey":"257ef2d4-413c-4274-b8a3-42edf7e3e6d5","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"153","SessionOnDemand":"False","SessionTitle":"Natural Killer (NK) Cells: From Cancer Orchestrators to Car-NK Therapy","ShowChatLink":"false","Start":"4\/9\/2022 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Katayoun Rezvani<\/i><\/u><\/presenter>. UT MD Anderson Cancer Center, Houston, TX","CSlideId":"","ControlKey":"7da00e8e-df5b-4926-a338-3c69a430d3f0","ControlNumber":"4711","DisclosureBlock":"<b>&nbsp;K. Rezvani, <\/b> <br><b>Takeda Pharmaceutical<\/b> Other Intellectual Property, Yes. <br><b>Affimed<\/b> Other Intellectual Property, Yes. <br><b>GemoAb<\/b> Independent Contractor, Grant\/Contract, Yes. <br><b>AvengeBio<\/b> Independent Contractor, Grant\/Contract, Yes. <br><b>Virogin<\/b> Independent Contractor, Grant\/Contract, Yes. <br><b>GSK<\/b> Independent Contractor, Grant\/Contract, Yes. <br><b>Caribou<\/b> Independent Contractor, Stock, Grant\/Contract, Yes. <br><b>Bayer<\/b> Independent Contractor, Grant\/Contract, Yes.","End":"4\/9\/2022 10:20:00 AM","HasWebcast":null,"Highlights":[],"Id":"382","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Katayoun Rezvani, MD","PresenterKey":"8aa7627c-33fc-4159-a875-afdc6455f527","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Engineered NK cells: The next frontier in cancer immunotherapy","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"153","SessionOnDemand":"False","SessionTitle":"Natural Killer (NK) Cells: From Cancer Orchestrators to Car-NK Therapy","ShowChatLink":"false","Start":"4\/9\/2022 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Engineered NK cells: The next frontier in cancer immunotherapy","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"cd0b06e3-3a95-4da4-921f-aa9a5304b0b7","ControlNumber":"4699","DisclosureBlock":"","End":"4\/9\/2022 10:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"379","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"153","SessionOnDemand":"False","SessionTitle":"Natural Killer (NK) Cells: From Cancer Orchestrators to Car-NK Therapy","ShowChatLink":"false","Start":"4\/9\/2022 10:20:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Eric Vivier<\/i><\/u><\/presenter>. Centre d'Immunologie INSERM, Marseille, France","CSlideId":"","ControlKey":"82d1319f-6948-4e3b-aecc-50b9b15cab97","ControlNumber":"4698","DisclosureBlock":"","End":"4\/9\/2022 10:50:00 AM","HasWebcast":null,"Highlights":[],"Id":"378","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Eric Vivier, PhD","PresenterKey":"257ef2d4-413c-4274-b8a3-42edf7e3e6d5","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"ANKET: Antibody-dependent NK cell engager therapeutics","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"153","SessionOnDemand":"False","SessionTitle":"Natural Killer (NK) Cells: From Cancer Orchestrators to Car-NK Therapy","ShowChatLink":"false","Start":"4\/9\/2022 10:30:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"ANKET: Antibody-dependent NK cell engager therapeutics","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"9785ff35-8498-460f-91df-9401620ece24","ControlNumber":"4700","DisclosureBlock":"","End":"4\/9\/2022 11:00:00 AM","HasWebcast":null,"Highlights":[],"Id":"380","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"153","SessionOnDemand":"False","SessionTitle":"Natural Killer (NK) Cells: From Cancer Orchestrators to Car-NK Therapy","ShowChatLink":"false","Start":"4\/9\/2022 10:50:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Yvonne Y. Chen<\/i><\/u><\/presenter>. University of California Los Angeles, Los Angeles, CA","CSlideId":"","ControlKey":"3c6a297f-9d4b-4063-92e2-6123e96bdf23","ControlNumber":"4706","DisclosureBlock":"","End":"4\/9\/2022 11:20:00 AM","HasWebcast":null,"Highlights":[],"Id":"381","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Yvonne Chen, PhD","PresenterKey":"b9d038f1-e0a1-482a-8cbe-a30bab651b8a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Expanding the cell-therapy arsenal: CAR-T versus CAR-NK in 2022","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"153","SessionOnDemand":"False","SessionTitle":"Natural Killer (NK) Cells: From Cancer Orchestrators to Car-NK Therapy","ShowChatLink":"false","Start":"4\/9\/2022 11:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Expanding the cell-therapy arsenal: CAR-T versus CAR-NK in 2022","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"8405b40b-4d31-43b3-8635-77e5a811f047","ControlNumber":"4712","DisclosureBlock":"","End":"4\/9\/2022 11:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"383","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"153","SessionOnDemand":"False","SessionTitle":"Natural Killer (NK) Cells: From Cancer Orchestrators to Car-NK Therapy","ShowChatLink":"false","Start":"4\/9\/2022 11:20:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""}]